Dennis Ding
Stock Analyst at Jefferies
(0)
# 4902
Out of 5,372 analysts
19
Total ratings
14.29%
Success rate
-22.39%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
MLYS Mineralys Therapeuti... | Initiates Coverage On: Hold | 15 15 | 13.94 | 7.6% | 1 | Jun 11, 2025 | |
CRNX Crinetics Pharmaceut... | Upgrades: Buy | 55 | 30.87 | 78.17% | 1 | Jan 22, 2025 | |
IKT Inhibikase Therapeut... | Initiates Coverage On: Buy | 8 | 1.79 | 346.93% | 1 | Nov 8, 2024 | |
ASMB Assembly Biosciences | Upgrades: Buy | 2 35 | 17 | 105.88% | 1 | Sep 20, 2024 | |
FOLD Amicus Therapeutics | Initiates Coverage On: Buy | 18 | 5.84 | 208.22% | 1 | Sep 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 5 7 | 3.48 | 101.15% | 2 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 8 6 | 4.82 | 24.48% | 1 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 500 25 | 10.91 | 129.15% | 1 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 648 | n/a | n/a | 1 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 35 22 | 71.36 | -69.17% | 1 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 24 | 18.87 | 27.19% | 1 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Oct 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 30 | n/a | n/a | 1 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 25 | n/a | n/a | 1 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 195 52 | n/a | n/a | 2 | Nov 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 11.1 | -9.91% | 1 | Oct 26, 2021 |